ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Transition to generic dolutegravir: immunologic, virologic, and metabolic outcomes in a resource-limited setting.

Aya M AbdelMagid et al.PubMed ↗Publisher ↗

No numbers read from the abstract.